CardioVascular BioTherapeutics, Inc.
Cardio Vascular Bio Therapeutics - CVBT is a biopharmaceutical company established to commercialize the breakthrough therapy developed by Dr. Thomas-Joseph Stegmann to treat coronary artery disease with a process known as angiogenesis. The treatment consi
Angiogenesis, ACORD, ACORD clinical trial, ACORD clinical trials, ACORD Phase II trial, CVBT Clinical Trial, CVBT ACORD Trial, ACORD Heart Trial, New Vessel Growth, Human Growth Factors, Coronary Heart Disease, Coronary Artery Disease, Adjunct Bypass Surg
Is this your site? Certify your site and update informations
